---
title: "COVID-19 and later risk of neurodegenerative and neurological disorders in vaccinated and unvaccin"
id: "medrxiv-19-association-of-covid-19-with-neurodegenerative-and-neurological-disorders-in"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-19-association-of-covid-19-with-neurodegenerative-and-neurological-disorders-in"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.30.26366919v1?rss=1"
published_at: "2026-11-01T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# COVID-19 and later risk of neurodegenerative and neurological disorders in vaccinated and unvaccin
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-19-association-of-covid-19-with-neurodegenerative-and-neurological-disorders-in
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.30.26366919v1?rss=1)
- **Published At:** 2026-11-01T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The investigators used linked primary care records from **OpenSAFELY-TPP** covering 18.3 million adults registered with English general practices to study neurological outcomes after SARS-CoV-2 infection. - Three exposure cohorts were defined with up to 5.5 years of follow-up: pre-vaccination (COVID-19 Jan 2020–Jun 2021), and vaccinated and unvaccinated cohorts (COVID-19 Jun–Dec 2021). - The study team estimated adjusted hazard ratios (aHRs) for incident **cognitive impairment** and **dementia** after COVID-19 and compared incidence with people without COVID-19 or before infection. - Short-term (weeks 0–4) incidence was markedly increased across cohorts: cognitive impairment aHRs reported were 4.02 (pre-vaccination), 2.24 (vaccinated), and 4.38 (unvaccinated); dementia aHRs were 5.05, 2.05, and 8.69 respectively. - Elevated incidence persisted long term (up to 4 years) for cognitive impairment and dementia, with stronger signals among those hospitalised with COVID-19 (aHRs reported for cognitive impairment/dementia ranged around 1.27–1.55 and 1.32–1.48 across cohorts). - The authors also analysed Parkinson’s disease, restless leg syndrome, REM sleep disorder, motor neuron disease, multiple sclerosis, and migraine; the Abstract reports incidence elevations were most prominent for cognitive outcomes. - The preprint status and the authors’ statement that long-term evidence remains limited are explicitly reported; ethical approvals and data governance (Health Research Authority; University of Bristol committee) are documented. - Data access is restricted; analysis code and the OpenSAFELY pipeline are available on GitHub as described by the authors. - Clinical implication suggested: patients, especially those hospitalised or unvaccinated, may need additional routine assessment for persistent or new cognitive concerns.
## Clinical Analysis & Structured Key Points
Association of COVID-19 with neurodegenerative and neurological disorders in vaccinated and unvaccinated people | medRxiv Skip to main content Association of COVID-19 with neurodegenerative and neurological disorders in vaccinated and unvaccinated people Harry Mason , Mengxuan Zou , Emily Eyles , Jose Ignacio Cuitun Coronado , Paul Madley-Dowd , Marwa Al Arab , Yinghui Wei , View ORCID Profile Genevieve Cezard , View ORCID Profile Tom M Palmer , Amelia Green , Alex J Walker , Simon Davy , View ORCID Profile Louis Fisher , Amir Mehrkar , Seb Bacon , View ORCID Profile Ben Goldacre , Nishi Chaturvedi , Jonathan A C Sterne , Rachel Denholm , View ORCID Profile Elizabeth Coulthard , View ORCID Profile Venexia Walker doi: https://doi.org/10.64898/2026.10.30.26366919 Harry Mason 1 University of Bristol; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Mengxuan Zou 1 University of Bristol; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Emily Eyles 1 University of Bristol; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jose Ignacio Cuitun Coronado 2 University of Leeds; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Paul Madley-Dowd 1 University of Bristol; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Marwa Al Arab 1 University of Bristol; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Yinghui Wei 3 University of Exeter; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Genevieve Cezard 4 University of Cambridge; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Genevieve Cezard Tom M Palmer 1 University of Bristol; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Tom M Palmer Amelia Green 5 University of Oxford; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Alex J Walker 1 University of Bristol; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Simon Davy 5 University of Oxford; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Louis Fisher 5 University of Oxford; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Louis Fisher Amir Mehrkar 5 University of Oxford; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Seb Bacon 5 University of Oxford; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ben Goldacre 5 University of Oxford; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Ben Goldacre Nishi Chaturvedi 6 University College London Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jonathan A C Sterne 1 University of Bristol; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Rachel Denholm 1 University of Bristol; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Elizabeth Coulthard 1 University of Bristol; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Elizabeth Coulthard Venexia Walker 1 University of Bristol; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Venexia Walker For correspondence: venexia.walker{at}bristol.ac.uk Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Introduction: COVID-19 has been linked to neuropathology, neurological symptoms, and diagnoses of neurological illnesses. Evidence regarding the long-term impact of COVID-19 on neurodegenerative and neurological disorders is still limited. Methods: We investigated associations of COVID-19 with neurodegenerative and neurological disorders by vaccination status in both hospitalised patients and the general population in the largest and longest study to date. We used OpenSAFELY-TPP to access linked electronic health records from 18.3 million adults registered with English GPs. We defined three cohorts with up to 5.5 years follow-up: pre-vaccination (exposed to COVID-19 January 2020-June 2021), and vaccinated and unvaccinated (exposed June-December 2021). We estimated adjusted hazard ratios (aHRs) comparing the incidence of cognitive impairment and dementia after diagnosis of COVID-19 with before or without COVID-19. We also studied Parkinson's disease, restless leg syndrome, rapid eye movement sleep disorder, motor neuron disease, multiple sclerosis, and migraine. Results: Incidence of most outcomes was elevated during weeks 0-4 after COVID-19 (cognitive impairment/dementia aHRs; pre-vaccination: 4.02 (3.74-4.32)/5.05 (4.63-5.52), vaccinated: 2.24 (2.05-2.45)/2.05 (1.77-2.37), unvaccinated: 4.38 (3.45-5.55)/8.69 (6.13-12.32)). Incidence remained elevated up to 4 years after COVID-19, especially in those hospitalised with COVID-19 (cognitive impairment/dementia aHRs; pre-vaccination: 1.49 (1.35-1.64)/ 1.39 (1.21-1.60), vaccinated: 1.27 (1.04-1.54)/1.32 (1.02-1.71), unvaccinated: 1.55 (1.11-2.16)/1.48 (1.00-2.20)). Conclusion: Incidence of cognitive impairment and dementia were elevated shortly after COVID-19. Incidence of cognitive impairment remained elevated in the longer term, particularly among unvaccinated individuals and/or those hospitalised with COVID-19. These patients may require additional assessment during routine care to evaluate persistent or new cognitive concerns. Competing Interest Statement BG has received research funding from the Bennett Foundation, the Laura and John Arnold Foundation, the National Institute for Health and Care Research (NIHR), the NIHR School of Primary Care Research, NHS England, the NIHR Oxford Biomedical Research Centre, the Mohn-Westlake Foundation, NIHR Applied Research Collaboration Oxford and Thames Valley, the Wellcome Trust, the Good Thinking Foundation, Health Data Research UK, the Health Foundation, the World Health Organisation, UKRI MRC, Asthma UK, the British Lung Foundation, and the Longitudinal Health and Wellbeing strand of the National Core Studies programme; he has previously been a Non-Executive Director at NHS Digital; he also receives personal income from speaking and writing for lay audiences on the misuse of science. NC receives funds from AstraZeneca to serve on clinical trial Data Safety and Monitoring Committees. All other authors report no conflicts. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Health Research Authority (REC reference 22/PR/0095) and the University of Bristol's Faculty of Health Sciences Ethics Committee [reference 117269] gave ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All non-disclosive data produced in the present work are contained in the manuscript. Access to the underlying identifiable and potentially re-identifiable pseudonymised electronic health record data is tightly governed by various legislative and regulatory frameworks, and restricted by best practice. The data in OpenSAFELY is drawn from General Practice data across England where TPP is the data processor. TPP developers initiate an automated process to create pseudonymised records in the core OpenSAFELY database, which are copies of key structured data tables in the identifiable records. These pseudonymised records are linked onto key external data resources that have also been pseudonymised via SHA-512 one-way hashing of NHS numbers using a shared salt. Bennett Institute for Applied Data Science developers and PIs holding contracts with NHS England have access to the OpenSAFELY pseudonymised data tables as needed to develop the OpenSAFELY tools. These tools in turn enable researchers with OpenSAFELY data access agreements to write and execute code for data management and data analysis without direct access to the underlying raw pseudonymised patient data, and to review the outputs of this code. All code for the full data management pipeline - from raw data to completed results for this analysis - and for the OpenSAFELY platform as a whole is available for review at https://github.com/OpenSAFELY. Funder Information Declared National Institute for Health and Care Research (NIHR) , COV-LT-0009; COV-LT2-0073; NIHR135559; NIHR203312 UK Research and Innovation (UKRI) , COV-LT-0009; MR/W021358/1; MC_PC_20058; MC_PC_20030 Medical Research Council (MRC) , MR/V015737/1; MC_PC_20059; MR/W016729/1; MC_UU_00032/2; MC_UU_00032/3 Wellcome Trust , 222097/Z/20/Z Health Data Research UK (HDR UK) , HDRUK2023.0028; HDR-23012; HDRUK2021.000 Engineering and Physical Sciences Research Council (EPSRC) , EP/X031349/1 British Heart Foundation (BHF) , RG/F/23/110103; CH/12/2/29428; RE/18/1/34212; RE/24/130011 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Back to top Previous Next Posted November 01, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Association of COVID-19 with neurodegenerative and neurological disorders in vaccinated and unvaccinated people Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Association of COVID-19 with neurodegenerative and neurological disorders in vaccinated and unvaccinated people Harry Mason , Mengxuan Zou , Emily Eyles , Jose Ignacio Cuitun Coronado , Paul Madley-Dowd , Marwa Al Arab , Yinghui Wei , Genevieve Cezard , Tom M Palmer , Amelia Green , Alex J Walker , Simon Davy , Louis Fisher , Amir Mehrkar , Seb Bacon , Ben Goldacre , Nishi Chaturvedi , Jonathan A C Sterne , Rachel Denholm , Elizabeth Coulthard , Venexia Walker medRxiv 2026.10.30.26366919; doi: https://doi.org/10.64898/2026.10.30.26366919 Share This Article: Copy Citation Tools Association of COVID-19 with neurodegenerative and neurological disorders in vaccinated and unvaccinated people Harry Mason , Mengxuan Zou , Emily Eyles , Jose Ignacio Cuitun Coronado , Paul Madley-Dowd , Marwa Al Arab , Yinghui Wei , Genevieve Cezard , Tom M Palmer , Amelia Green , Alex J Walker , Simon Davy , Louis Fisher , Amir Mehrkar , Seb Bacon , Ben Goldacre , Nishi Chaturvedi , Jonathan A C Sterne , Rachel Denholm , Elizabeth Coulthard , Venexia Walker medRxiv 2026.10.30.26366919; doi: https://doi.org/10.64898/2026.10.30.26366919 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (637) Allergy and Immunology (917) Anesthesia (348) Cardiovascular Medicine (4975) Dentistry and Oral Medicine (493) Dermatology (426) Emergency Medicine (674) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1682) Epidemiology (16207) Forensic Medicine (36) Gastroenterology (1238) Genetic and Genomic Medicine (7251) Geriatric Medicine (751) Health Economics (1092) Health Informatics (5262) Health Policy (1463) Health Systems and Quality Improvement (1825) Hematology (599) HIV/AIDS (1375) Infectious Diseases (except HIV/AIDS) (16466) Intensive Care and Critical Care Medicine (1199) Medical Education (697) Medical Ethics (156) Nephrology (747) Neurology (7553) Nursing (377) Nutrition (1120) Obstetrics and Gynecology (1293) Occupational and Environmental Health (1038) Oncology (3731) Ophthalmology (1087) Orthopedics (407) Otolaryngology (464) Pain Medicine (499) Palliative Medicine (143) Pathology (720) Pediatrics (1853) Pharmacology and Therapeutics (752) Primary Care Research (784) Psychiatry and Clinical Psychology (6102) Public and Global Health (9960) Radiology and Imaging (2515) Rehabilitation Medicine and Physical Therapy (1506) Respiratory Medicine (1264) Rheumatology (657) Sexual and Reproductive Health (799) Sports Medicine (595) Surgery (799) Toxicology (109) Transplantation (318) Urology (307)
## Related Clinical Research

- [U.S. POINTER: Structured lifestyle program slows brain aging and cardiometabolic risk over 24 mont](https://medichelpline.com/clinical-feed/medical-news-today-0-combining-physical-mental-and-social-habits-slows-brain-aging-in-2-year-trial.md)
- [fMRI-based ARC tool differentiates SuperAgers from Alzheimer’s with strong AUC](https://medichelpline.com/clinical-feed/medical-news-today-2-new-brain-imaging-tool-distinguishes-between-alzheimer-s-disease-and-superagers.md)
- [Climate change worsens health for people with chronic illness](https://medichelpline.com/clinical-feed/stat-news-1-opinion-climate-change-is-making-people-with-chronic-illness-even-sicker.md)
- [Tongue–Jaw Timing Differences in ALS Versus Other Dysarthrias During [kai]](https://medichelpline.com/clinical-feed/medrxiv-2-inter-articulatory-timing-of-vocalic-tongue-body-and-jaw-movements-across.md)
- [High-resolution map of the basal ganglia reveals cell types tied to Parkinson’s and schizophrenia](https://medichelpline.com/clinical-feed/stat-news-1-stat-scientists-debut-map-of-basal-ganglia-a-key-brain-region-involved-in-an.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.